An editorial published in Frontiers in Public Health summarises six research papers presented at the International Food Addiction and Comorbidities Conference (IFACC) 2025, held in London on 4 and 5 September 2025. The collection, edited by Nicole Avena of the Icahn School of Medicine at Mount Sinai and Octavian Vasiliu of the University of Medicine and Pharmacy “Carol Davila” in Bucharest, maps current thinking on ultra-processed food addiction (UPFA) and its links to metabolic and psychiatric conditions.

According to the editorial, the food industry’s shift toward ultra-processed foods — products assembled from refined ingredients and additives that boost palatability and shelf life — has been linked in an umbrella review of epidemiological meta-analyses to 32 adverse health outcomes. The strongest evidence connects UPF consumption to cardiovascular mortality, type 2 diabetes, and common mental disorders.

Food addiction, most often measured using the Yale Food Addiction Scale 2.0 (YFAS 2.0), which adapts the DSM-5 criteria for substance use disorders to eating behaviour, is estimated to affect about 14% of adults and 12% of children globally, the editorial reports. Rates are significantly higher among people with binge eating disorder or obesity. Foods combining refined carbohydrates and added fats appear to be the most implicated, and some researchers have argued that highly processed foods meet the same criteria once used to declare tobacco addictive. An international Delphi consensus has since described UPFA as a distinct condition that may co-occur with eating disorders.

The editorial notes that important questions remain unresolved, including whether the addictive process lies in the food itself or in the eating behaviour, how the construct should be assessed across different cultures, and which interventions are both effective and safe. The work builds on earlier animal research by Hoebel, Avena and colleagues, which showed that intermittent access to sugar could produce binge-like consumption, repeated dopamine release in the nucleus accumbens, opioid-system adaptations, and withdrawal-like responses in rodents. The authors caution that these animal findings do not establish that sugar produces a substance use disorder in humans, but they identify testable neurobiological mechanisms relevant to compulsive consumption of highly processed foods.

Refining the construct and its assessment

Two of the six papers address what exactly should be measured in the field of UPFA. Bennett et al. evaluated CRAVED, a six-item yes/no screening instrument for UPFA, in 117 adults enrolled in a community program. According to the editorial, CRAVED correlated moderately with YFAS 2.0 and Binge Eating Scale scores and acceptably discriminated YFAS-defined food addiction, with high sensitivity at its original cut-off. However, its internal consistency was modest, and the authors present it as a screening rather than a diagnostic tool.

Tarman introduced the concept of "volume addiction" as a putative phenotype within compulsive high-volume eating, where gastric distension — rather than palatability or caloric density — becomes the main reinforcer. The editorial notes that this perspective is clinically relevant because such patients may shift toward large amounts of low-energy foods after bariatric surgery or during treatment with GLP-1 receptor agonists, a presentation that current food addiction and binge eating criteria may overlook.

Cultural and regional perspectives on food addiction

Two additional studies explore how food addiction manifests in distinct cultural settings. Mahoney et al. studied 251 university students in the United States and South Korea, observing significant links between YFAS 2.0 scores and emotional eating in both groups, with a more pronounced connection among Korean participants. Even after controlling for demographic factors, emotional eating remained a strong predictor of food addiction symptoms, according to the editorial, this finding reinforces the idea that addressing emotional eating can be a common intervention point across different populations. Jain et al. performed the initial scoping review of food addiction research in India, uncovering just 10 studies, which were predominantly cross-sectional, geographically limited, and used translated YFAS versions that had not been locally validated. There was considerable variation in prevalence rates, and the researchers noted culturally specific factors like academic pressure, dormitory living, and social celebrations, as well as a lack of research on older adults and clinical groups.

From conceptual models to interventions

The remaining two articles move toward clinical management. Bennett et al. reported that participants in Liberate, an online, community-based psychoeducational program grounded in an addiction framework, showed substantial reductions in binge eating severity after 8 weeks, which were largely maintained at 6 months. The editorial notes that in the absence of a control group, these results remain preliminary, but they are relevant to the concern that abstinence-oriented dietary approaches may worsen disordered eating.

Vasiliu put forward a stepped-care case management approach for UPFA based on the Research Domain Criteria (RDoC) framework, where a case manager heads a multidisciplinary team that customizes psychotherapeutic, nutritional, pharmacological, and lifestyle treatments according to severity, comorbidity, and the influence of each RDoC domain. Since the majority of its elements are derived from binge eating disorder, substance use disorders, and obesity, the model is presented as a framework for testing rather than a set of recommendations.

Conclusions and future directions

The editorial concludes that these six contributions show a field moving from general questions about a poorly defined concept of food addiction to more practical questions of how to detect UPFA briefly and reliably, how its expression varies across cultures and phenotypes, and how care can be organised for people whose addictive-like eating coexists with metabolic and psychiatric disorders. The articles also expose shared limitations: small or self-selected samples, cross-sectional designs, reliance on self-report, and assessment tools that still need cross-cultural validation.

Future research, the editorial states, should prioritise controlled intervention trials, longitudinal and representative cohorts, and studies that clarify the boundaries between food addiction, binge eating, and other eating disorders. The emergence of GLP-1 receptor agonists — relevant to both the volume addiction phenotype described by Tarman and the pharmacological options considered by Vasiliu — creates a new opportunity for bidirectional translation between obesity medicine and addiction neuroscience. Whether these medications directly improve UPFA, independently of weight loss or appetite suppression, remains uncertain. Controlled studies should distinguish changes in food craving, loss of control, binge frequency, nutritional status, and eating disorder psychopathology from weight reduction alone, and particular caution is needed in patients with restrictive eating disorders, malnutrition, or other clinically significant eating pathology.

The editorial also emphasises the importance of translating this knowledge to the general population, since increasing public awareness of disordered eating through integrative educational models may reduce stigma and encourage earlier help-seeking.